Roger Dailey M.D., FACS
Roger Dailey, M.D., FACS, a professor of ophthalmology at the OHSU School of Medicine, 2019. (OHSU/Kristyna Wentz-Graff)
Thyroid eye disease treatment
Judy Bachman of Portland participated in a clinical trial that treated symptoms of thyroid eye disease, a condition that can cause eyes to bulge outward, double vision, and eyelids to retract and not fully close. Bachman testified before the FDA about her experience with the drug teprotumumab and how it allowed her to get her life back. (OHSU/Kristyna Wentz-Graff)
Thyroid eye disease treatment
Judy Bachman of Portland participated in a clinical trial that treated symptoms of thyroid eye disease, a condition that can cause eyes to bulge outward, double vision, and eyelids to retract and not fully close. Bachman testified before the FDA about her experience with the drug teprotumumab and how it allowed her to get her life back. (OHSU/Kristyna Wentz-Graff)
Thyroid eye disease treatment
Dr. Roger Dailey examines Judy Bachman of Portland, who participated in a clinical trial that treated symptoms of thyroid eye disease. Bachman and Dailey testified before the FDA the benefits of the medication. (OHSU/Kristyna Wentz-Graff)
Thyroid eye disease treatment
Dr. Roger Dailey examines Judy Bachman of Portland, who participated in a clinical trial that treated symptoms of thyroid eye disease. Bachman and Dailey testified before the FDA the benefits of the medication. (OHSU/Kristyna Wentz-Graff)
Thyroid eye disease treatment
Judy Bachman of Portland, who participated in a clinical trial that treated symptoms of thyroid eye disease, a condition that can cause eyes to bulge outward, double vision, and eyelids to retract and not fully close. Bachman testified before the FDA about her experience with the drug teprotumumab and how it allowed her to get her life back. (OHSU)
Thyroid eye disease treatment
Judy Bachman of Portland, who participated in a clinical trial that treated symptoms of thyroid eye disease, a condition that can cause eyes to bulge outward, double vision, and eyelids to retract and not fully close. Bachman testified before the FDA about her experience with the drug teprotumumab and how it allowed her to get her life back. (OHSU)
Thyroid eye disease treatment
Dr. Roger Dailey examines Judy Bachman of Portland, who participated in a clinical trial that treated symptoms of thyroid eye disease. Bachman and Dailey testified before the FDA the benefits of the medication. (OHSU/Kristyna Wentz-Graff)
Harney District Hospital Community Assistance
Savanna Cate, (left) program outreach coordinator for the Harney District Hospital Community Assistance for Neighbors with Cancer Program, shares information with patient Debbie Pike. The Burns, Oregon, program received a new grant to conduct a needs assessment of cancer patients in Harney County to identify cancer-related needs and barriers to care. (Photo courtesy Harney District Hospital Community Assistance for Neighbors with Cancer Program)
